1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsSupports small businesses in developing biomedical technologies.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Small businesses in the U. S. developing biomedical technologies. Confirm the full requirements in the official notice before applying.
The current listing shows up to $1.5 million over Phase I and II. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Biomedical Technologies SBIR Program is funded by NSF. Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Small Business Technology Transfer (STTR) Program (Parent STTR [R41/R42]) is sponsored by National Institutes of Health (NIH), Department of Health and Human Services (HHS), Centers for Disease Control (CDC). This omnibus solicitation supports cooperative research and development between small businesses and non-profit research institutions to advance early-stage biomedical commercialization. It is designed to foster technology transfer.
Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs (Omnibus Solicitations) is sponsored by National Institutes of Health (NIH). The NIH SBIR/STTR programs provide non-dilutive funding for groundbreaking research and development projects that address critical needs in healthcare and biomedical science. These omnibus solicitations welcome investigator-initiated ideas across a broad range of topics relevant to NIH's mission areas. Applications are accepted three times per year.
Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional) is sponsored by National Institutes of Health (NIH). This program provides additional funding for small businesses that have successfully completed Phase II SBIR projects and require extraordinary time and effort in the R&D phase to reach the marketplace. It focuses on biomedical technologies with public health impact.
TCUP lists eight funding tracks and roughly $10.3M a year, but the October 14, 2026 deadline applies to only three of them — CHAI, Pre-TI, and TCUP Partnerships — and each carries a restriction that disqualifies most applicants. Here is the track-by-track math.
Read articleNSF 26-513 makes roughly $100 million available for up to 10 State and Regional AI Infrastructure Hubs at $4M to $12M each over five years. One award per state or multi-state region. One proposal per organization. And NSF is not buying you GPUs — it funds the coordination, the workforce and the faculty training, while the compute has to come from partners you have to already have.
Read articleAs of September 12, NSF had obligated $6.3 billion across 6,200 grants versus $8.1 billion and 8,600 last year. AHRQ has made 61 awards. Judge Allison Burroughs ordered the government to report by September 28 on whether IES will obligate $180 million before it expires. Here is what actually happens to the money on October 1 — and what it means for your FY2027 application.
Read article